RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 162 filers reported holding RELAY THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,520 | -21.4% | 1,000 | 0.0% | 0.00% | – |
| Q1 2024 | $8,300 | -24.6% | 1,000 | 0.0% | 0.00% | – |
| Q4 2023 | $11,010 | +30.9% | 1,000 | 0.0% | 0.00% | – |
| Q3 2023 | $8,410 | -33.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2023 | $12,560 | -23.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $16,470 | +10.2% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $14,940 | -32.1% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $22,000 | +29.4% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $17,000 | -43.3% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $30,000 | -3.2% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $31,000 | -3.1% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $32,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 5,998,574 | $75,342,089 | 6.58% |
| Nextech Invest Ltd. | 948,659 | $11,915,157 | 4.05% |
| MPM BioImpact LLC | 1,354,368 | $17,010,862 | 3.42% |
| Finepoint Capital LP | 701,570 | $8,811,719 | 3.05% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $350,486,335 | 2.67% |
| EcoR1 Capital, LLC | 4,163,824 | $52,297,629 | 1.28% |
| BVF INC/IL | 3,120,521 | $39,193,744 | 1.09% |
| Integral Health Asset Management, LLC | 700,000 | $8,792,000 | 1.09% |
| Boxer Capital, LLC | 1,819,132 | $22,848 | 1.06% |
| Alphabet Inc. | 1,568,753 | $19,703,537 | 1.06% |